MustGrow Biologics Corp. is experiencing a notable decline in its stock performance, raising concerns among investors.
MustGrow Biologics Corp. (MGRO.V) is facing a downturn, with its stock price dropping by 1.14% in today’s session, closing at CA$0.43. This decline comes amidst a lack of significant news or events that could explain the downward movement.
Advertisement
MustGrow Biologics Corp.
MGRO.V
MGRO.V
MustGrow Biologics Corp.
WealthAwesomeMarket cap
$30.98M
52W high
$0.94
52W low
$0.29
1W change
+4.76%
Beta
0.41
Analyst Price Targets
Based on analyst covering MGRO · as of Sep 30, 2026
Wall Street analysts forecast MGRO stock price to rise 470.5% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$2.51
+470.5% Upside
Previously C$2.70 on Sep 17, 2026
Current Price
C$0.44
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MGRO's historical volatility
30-Day Vol
92.5%
Annualized
90-Day Vol
81.0%
Annualized
Trend (90d)
+40.0%
Annualized drift
90d Mean
C$0.51
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.46 | C$0.34 – C$0.64 |
| 60 trading days | C$0.48 | C$0.31 – C$0.76 |
| 90 trading days | C$0.51 | C$0.29 – C$0.88 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should be cautious as MustGrow's stock shows signs of weakness, particularly given its recent performance and the absence of positive catalysts.
MustGrow's Market Cap Stands at CA$30.98 Million
With a market cap of CA$30.98 million and a P/E ratio that is not applicable due to ongoing losses, investors may want to reassess their positions in light of today's performance.
Bull case
Despite today’s decline, MustGrow has shown potential in the past, especially with collaborations like the recent milestone payment from Bayer AG. This partnership could open doors for future growth opportunities.
Bear case
The current drop in stock price highlights ongoing concerns about the company's profitability and market position. With a negative profit margin and no current dividend yield, investors might want to think carefully about their investments in MustGrow.
Advertisement
Market Performance Overview
MustGrow Biologics Corp. is down 1.14% today, reflecting broader concerns about its financial health and market viability. The company's current market cap of CA$30.98 million and a troubling profit margin of -0.5853 indicate potential challenges ahead. Investors may want to keep an eye on upcoming announcements or financial results that could impact stock performance.
Recent Developments and Future Outlook
While MustGrow recently secured a milestone payment from Bayer AG, the absence of significant news today has contributed to the stock's decline. Investors should consider the implications of the company's recent financial results and its ongoing efforts to enhance market visibility through investor relations agreements. For more details on MustGrow's performance, check out their latest financial results and market awareness initiatives.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
